JashinJoaquinWuMD
Dermatology • Irvine, CAFounder and CEO, Dermatology Research and Education Foundation
Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NA
Irvine, CA 92620
Education & Training
University of California (Irvine)Residency, Dermatology, 2005 - 2008
Baylor College of MedicineInternship, Internal Medicine, 2002 - 2003
Northwestern University The Feinberg School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
TX State Medical License 2003 - 2004- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Publications & Presentations
PubMed
- 333 citationsPrevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studiesFarzad Alinaghi, Monika Calov, Lars Erik Kristensen, Dafna D. Gladman, Laura C. Coates
Journal of the American Academy of Dermatology. 2019-01-01 - 165 citationsJoint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro
Journal of the American Academy of Dermatology. 2020-06-01 - 124 citationsJoint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily B. Wong, Reena N. Rupani
Journal of the American Academy of Dermatology. 2021-02-01
Journal Articles
- Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque PsoriasisAndrew Blauvelt, Craig L Leonardi, Jashin J Wu, JAMA Dermatology
- Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis FoundationRonald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA
Authored Content
- Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque PsoriasisApril 2020
Press Mentions
Dissatisfaction with Multiple Facets of Care Reported in Psoriasis & Psoriatic ArthritisNovember 17th, 2024- Topical Tapinarof and Roflumilast for Psoriasis: Where Do They Fit In?September 10th, 2024
- How Do Tapinarof and Roflumilast Creams Fit into Psoriasis Treatment?September 5th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
